GRK2 Enforces Androgen Receptor-Dependence in the Prostate and Prostate Tumors

Metastatic tumors that have become resistant to androgen deprivation therapy represent the major challenge in treating prostate cancer. Although these recurrent tumors typically remain dependent on the androgen receptor (AR), non-AR-driven tumors that also emerge are particularly deadly and becoming...

Descripción completa

Detalles Bibliográficos
Autores principales: Adler, Adam J., Mittal, Payal, Hagymasi, Adam T., Menoret, Antoine, Shen, Chen, Agliano, Federica, Wright, Kyle T., Grady, James J., Ling Kuo, Chia, Ballesteros, Enrique, Claffey, Kevin P., Vella, Anthony T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072002/
https://www.ncbi.nlm.nih.gov/pubmed/31959897
http://dx.doi.org/10.1038/s41388-020-1159-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072002/
https://www.ncbi.nlm.nih.gov/pubmed/31959897
http://dx.doi.org/10.1038/s41388-020-1159-x

Ejemplares similares